The Value of Stillness
Health Care: Drugs
Acura Pharmaceuticals Inc. (ACUR: NASDAQ)
$2.12 -0.01 | -0.47%
06/19/13 - 10:23 AM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 2.13 |
| 52 Week High | 4.50 |
| 52 Week Low | 1.06 |
| Avg. Daily Vol. (Mil) | 0.63 |
| Beta (3 year) | 1.74 |
| Share Related Items | |
| Mkt Cap (Mil) | 98.78 |
| Shares Out (Mil) | 46.38 |
| Float (Mil) | 12.77 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 10.00 |
| Current Ratio | 11.10 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 24.69K |
| Price/Book | 4.28 |
| Price/Cash Flow | -7.20 |
| Per Share Data | |
| Earnings | -0.24 |
| Sales | 0.00 |
| Book Value | 0.50 |
| Cash Flow | -0.30 |
| Business Summary | |
|---|---|
| Acura Pharmaceuticals, Inc. is a pharmaceutical company, which is engaged in the research, development and manufacture of product candidates providing abuse deterrent features and benefits. | |
| General Information | |
| 616 North North Court
Suite 120 Palatine, IL 60067 |
|
| www.acurapharm.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 15 | |
| CEO: Robert B. Jones | |
| Short Interest | |
| Current Month (Mil) | 1.05 |
| Previous Month (Mil) | 1.31 |
| Short Interest Ratio (Days) | 2.00 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -55.00 |
| Return on Investments | -60.00 |
| Profitability | |
| Gross Margin | n.a. |
| EBIT Margin | n.a. |
| Profit Margin | 0.00 |
Portfolios with ACUR
- Portfolio NameUser Type
- ContributorStocks Under-$10 Setting Up...
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorBreakout Stocks Of The Week...
- UserSUPRATRADE HOT STOCKS (BUY ...
- UserSUPRATRADE HOT STOCKS (BUY ...
- User©SUPRATRADE HOT STOCKS (...
- User©SUPRATRADE HOT STOCKS (...
Latest ACUR Headlines from TheStreet
- 5 Stocks Under $10 Set to Soar 04.18.13 | 02:04 pm
- 5 Stocks Poised for Breakouts 04.05.13 | 02:04 pm
- 4 Stocks Under $5 Moving Higher 10.11.12 | 03:10 pm
- Acura Pharmaceuticals Management Discusses Q2 2012 Results - Earnings Call Transcript 07.31.12 | 10:07 am
- 8 Stocks Under $10 Moving Higher 03.20.12 | 12:03 pm
- 7 Stocks Under $10 Moving Higher 11.30.11 | 12:11 pm
- Acura Stock Soars (ACUR) 09.30.11 | 02:09 pm
- Acura Stock Soars (ACUR) 08.15.11 | 12:08 pm
- Acura Pharmaceuticals Inc. Stock Upgraded (ACUR) 08.03.11 | 07:08 am
- Pfizer, Pain Therapeutics Drug Rejected by FDA 06.24.11 | 08:06 am
Press Releases for ACUR
- Pfizer And Acura Announce FDA Approval Of Oxectatm (Oxycodone HCL, USP) CII - Business Wire 06.20.11 | 07:06 am
- Kahn Swick & Foti, LLC And Former Louisiana State Attorney General Remind Investors With Large Financial Interests (Over $100,000) Of Important 11/9/2010 Deadline In Securities Class Action Against Acura Pharmaceuticals, Inc. - ACUR - Business Wire 11.03.10 | 05:11 pm
- The Shuman Law Firm Announces The Filing Of A Class Action Lawsuit Against Acura Pharmaceuticals, Inc. - Business Wire 10.21.10 | 02:10 pm
- Law Offices Of Howard G. Smith Announces Investigation On Behalf Of Shareholders Of Acura Pharmaceuticals, Inc. - Business Wire 09.14.10 | 08:09 pm
- Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Acura Pharmaceuticals, Inc. - Business Wire 09.14.10 | 07:09 pm
- The Law Office Of Robbins Umeda LLP Announces The Filing Of A Class Action Suit Against Acura Pharmaceuticals, Inc. - Business Wire 09.14.10 | 06:09 pm
- Law Office Of Jonathan M. Stein, P.L. Investigates Possible Breaches Of Fiduciary Duty By The Officers And Directors Of Acura Pharmaceuticals, Inc. - Business Wire 09.14.10 | 03:09 pm
Partner Headlines for ACUR
- Current Prime Pharma Entries In Anticipation Of Prime Time Exits - Seeking Alpha 11.06.12 | 09:11 am
- Acura Pharmaceuticals Announces Update on AVERSION Products - Benzinga 07.27.12 | 04:07 pm
- Healthcare Business Rewind: Furiex' GOOD NEWS, Pfizer TERMINATES Licenses - Wall St. Cheat Sheet 07.27.12 | 06:07 am
- 10 Biotech Stocks With 100% Upside In 2012: Part One - Seeking Alpha 02.09.12 | 10:02 am
- Building The Perfect Portfolio: Best Small Cap Stocks - Seeking Alpha 12.02.11 | 08:12 am
- Insider Buys May Send The Wrong Signals - Seeking Alpha 08.22.11 | 09:08 am
- Company News for June 21, 2011 - Corporate Summary - Zacks 06.21.11 | 10:06 am
- Acura Pharmaceuticals: FDA's Drug Decision Friday May Unlock Big Opportunity - Seeking Alpha 06.15.11 | 09:06 am
- 12 Healthcare Companies Looking at June Catalysts - Seeking Alpha 05.30.11 | 04:05 am
- King Pharma Files NDA for Pain Drug - Analyst Blog - Zacks 12.21.10 | 09:12 am
